We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Green Plains
GPRE
$1.24B
| $2.07M | 0.01% |
125,652
+9,807
| +8% | +$133K |
|
602
Celldex Therapeutics
CLDX
$2.73B
| $2.06M | 0.01% |
65,050
-49,180
| -43% | -$1.34M |
|
603
Century Communities
CCS
$1.86B
| $2.06M | 0.01% |
35,937
-5,901
| -14% | -$380K |
|
604
Tapestry
TPR
$29B
| $2.05M | 0.01% |
14,540
-6,700
| -32% | -$950K |
|
605
Sysco
SYY
$39.3B
| $2.04M | 0.01% |
28,667
-11,437
| -29% | -$945K |
|
606
Nicolet Bankshares
NIC
$3.57B
| $2.03M | 0.01% |
13,653
-522
| -4% | -$75.8K |
|
607
Novavax
NVAX
$1.3B
| $2.02M | 0.01% |
248,413
-81,073
| -25% | -$735K |
|
|
BKV
608
BKV Corp
BKV
$2.9B
| $2.02M | 0.01% |
70,822
+35,042
| +98% | +$1.02M |
|
609
Expedia Group
EXPE
$31.3B
| $2.01M | 0.01% |
8,702
-2,949
| -25% | -$724K |
|
610
Equity Residential
EQR
$25.6B
| $2M | 0.01% |
33,826
-10,941
| -24% | -$675K |
|
611
Snowflake
SNOW
$92.8B
| $1.99M | 0.01% |
13,213
-3,275
| -20% | -$606K |
|
|
ORKA
612
Oruka Therapeutics
ORKA
$5.58B
| $1.99M | 0.01% |
40,487
+2,002
| +5% | +$69.6K |
|
613
Mettler-Toledo International
MTD
$26B
| $1.98M | 0.01% |
1,570
-628
| -29% | -$847K |
|
614
Kenvue
KVUE
$36.7B
| $1.98M | 0.01% |
114,680
-45,766
| -29% | -$815K |
|
615
EPAM Systems
EPAM
$4.52B
| $1.97M | 0.01% |
14,519
-4,810
| -25% | -$822K |
|
616
Olema Pharmaceuticals
OLMA
$1B
| $1.96M | 0.01% |
131,520
+86,515
| +192% | +$1.93M |
|
617
Factset
FDS
$8.72B
| $1.96M | 0.01% |
9,018
-2,410
| -21% | -$562K |
|
618
Otis Worldwide
OTIS
$27B
| $1.95M | 0.01% |
25,311
-9,405
| -27% | -$823K |
|
619
Stoke Therapeutics
STOK
$1.8B
| $1.95M | 0.01% |
59,898
-30,295
| -34% | -$994K |
|
620
CMS Energy
CMS
$22.9B
| $1.92M | 0.01% |
24,796
-8,717
| -26% | -$647K |
|
621
Kimberly-Clark
KMB
$36.1B
| $1.92M | 0.01% |
19,864
-7,928
| -29% | -$811K |
|
622
Vericel Corp
VCEL
$2.28B
| $1.91M | 0.01% |
59,395
-16,202
| -21% | -$575K |
|
623
Capricor Therapeutics
CAPR
$1.1B
| $1.9M | 0.01% |
+62,353
| New | +$1.66M |
|
624
Xylem
XYL
$27.6B
| $1.9M | 0.01% |
15,859
-5,830
| -27% | -$765K |
|
625
Ingersoll Rand
IR
$32.7B
| $1.86M | 0.01% |
23,175
-8,855
| -28% | -$782K |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.